Key Senate Democrats are seeking a firm commitment from HHS secretary nominee Robert F. Kennedy Jr. to oppose pharmaceutical and GOP efforts to water down Medicare drug price negotiations. They note that an HHS statement put out Wednesday (Jan. 29) opens the door to changing the negotiation process and, while backing negotiations, doesn’t say the Trump administration will defend the underlying statute -- a point Kennedy also danced around at his Senate health committee confirmation hearing Thursday (Jan. 30). Hours...